283 related articles for article (PubMed ID: 19414923)
1. The pharmacokinetics of the lymphotropic nanoparticle MRI contrast agent ferumoxtran-10.
Islam T; Wolf G
Cancer Biomark; 2009; 5(2):69-73. PubMed ID: 19414923
[TBL] [Abstract][Full Text] [Related]
2. Preoperative diagnosis of lymph node metastases in gastric cancer by magnetic resonance imaging with ferumoxtran-10.
Tatsumi Y; Tanigawa N; Nishimura H; Nomura E; Mabuchi H; Matsuki M; Narabayashi I
Gastric Cancer; 2006; 9(2):120-8. PubMed ID: 16767368
[TBL] [Abstract][Full Text] [Related]
3. Ultrasmall superparamagnetic iron-oxide-enhanced MR imaging of normal bone marrow in rodents: original research original research.
Simon GH; Raatschen HJ; Wendland MF; von Vopelius-Feldt J; Fu Y; Chen MH; Daldrup-Link HE
Acad Radiol; 2005 Sep; 12(9):1190-7. PubMed ID: 16099684
[TBL] [Abstract][Full Text] [Related]
4. Splenic imaging with ultrasmall superparamagnetic iron oxide ferumoxtran-10 (AMI-7227): preliminary observations.
Harisinghani MG; Saini S; Weissleder R; Rubin D; deLange E; Harms S; Weinreb J; Small W; Sukerkar A; Brown JJ; Zelch J; Lucas M; Morris M; Hahn PF
J Comput Assist Tomogr; 2001; 25(5):770-6. PubMed ID: 11584239
[TBL] [Abstract][Full Text] [Related]
5. USPIO (Ferumoxtran-10)-enhanced MRI to visualize reticuloendothelial system cells in neonatal rats: feasibility and biodistribution study.
Azoulay R; Olivier P; Baud O; Verney C; Santus R; Robert P; Gressens P; Sebag G
J Magn Reson Imaging; 2008 Oct; 28(4):1046-52. PubMed ID: 18821607
[TBL] [Abstract][Full Text] [Related]
6. Overview of nanoparticle use in cancer imaging.
Islam T; Harisinghani MG
Cancer Biomark; 2009; 5(2):61-7. PubMed ID: 19414922
[TBL] [Abstract][Full Text] [Related]
7. Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors.
Varallyay P; Nesbit G; Muldoon LL; Nixon RR; Delashaw J; Cohen JI; Petrillo A; Rink D; Neuwelt EA
AJNR Am J Neuroradiol; 2002 Apr; 23(4):510-9. PubMed ID: 11950637
[TBL] [Abstract][Full Text] [Related]
8. Atorvastatin and uptake of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) in human monocyte-macrophages: implications for magnetic resonance imaging.
Müller K; Skepper JN; Tang TY; Graves MJ; Patterson AJ; Corot C; Lancelot E; Thompson PW; Brown AP; Gillard JH
Biomaterials; 2008 Jun; 29(17):2656-62. PubMed ID: 18377983
[TBL] [Abstract][Full Text] [Related]
9. MR lymphangiography: imaging strategies to optimize the imaging of lymph nodes with ferumoxtran-10.
Harisinghani MG; Dixon WT; Saksena MA; Brachtel E; Blezek DJ; Dhawale PJ; Torabi M; Hahn PF
Radiographics; 2004; 24(3):867-78. PubMed ID: 15143236
[TBL] [Abstract][Full Text] [Related]
10. Ferumoxtran-10-enhanced MR lymphangiography: does contrast-enhanced imaging alone suffice for accurate lymph node characterization?
Harisinghani MG; Saksena MA; Hahn PF; King B; Kim J; Torabi MT; Weissleder R
AJR Am J Roentgenol; 2006 Jan; 186(1):144-8. PubMed ID: 16357394
[TBL] [Abstract][Full Text] [Related]
11. Biodistribution of ultrasmall iron oxide particles in the rat liver.
Van Beers BE; Sempoux C; Materne R; Delos M; Smith AM
J Magn Reson Imaging; 2001 Apr; 13(4):594-9. PubMed ID: 11276104
[TBL] [Abstract][Full Text] [Related]
12. A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: implications for cellular magnetic resonance imaging.
Arbab AS; Wilson LB; Ashari P; Jordan EK; Lewis BK; Frank JA
NMR Biomed; 2005 Oct; 18(6):383-9. PubMed ID: 16013087
[TBL] [Abstract][Full Text] [Related]
13. Preclinical safety and pharmacokinetic profile of ferumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agent.
Bourrinet P; Bengele HH; Bonnemain B; Dencausse A; Idee JM; Jacobs PM; Lewis JM
Invest Radiol; 2006 Mar; 41(3):313-24. PubMed ID: 16481915
[TBL] [Abstract][Full Text] [Related]
14. Differential uptake of ferumoxtran-10 and ferumoxytol, ultrasmall superparamagnetic iron oxide contrast agents in rabbit: critical determinants of atherosclerotic plaque labeling.
Yancy AD; Olzinski AR; Hu TC; Lenhard SC; Aravindhan K; Gruver SM; Jacobs PM; Willette RN; Jucker BM
J Magn Reson Imaging; 2005 Apr; 21(4):432-42. PubMed ID: 15779033
[TBL] [Abstract][Full Text] [Related]
15. Ferumoxtran-10, a superparamagnetic iron oxide as a magnetic resonance enhancement agent for imaging lymph nodes: a phase 2 dose study.
Hudgins PA; Anzai Y; Morris MR; Lucas MA
AJNR Am J Neuroradiol; 2002 Apr; 23(4):649-56. PubMed ID: 11950660
[TBL] [Abstract][Full Text] [Related]
16. Real-time imaging of convection-enhanced delivery of viruses and virus-sized particles.
Szerlip NJ; Walbridge S; Yang L; Morrison PF; Degen JW; Jarrell ST; Kouri J; Kerr PB; Kotin R; Oldfield EH; Lonser RR
J Neurosurg; 2007 Sep; 107(3):560-7. PubMed ID: 17886556
[TBL] [Abstract][Full Text] [Related]
17. T1 and T2 relaxivity of intracellular and extracellular USPIO at 1.5T and 3T clinical MR scanning.
Simon GH; Bauer J; Saborovski O; Fu Y; Corot C; Wendland MF; Daldrup-Link HE
Eur Radiol; 2006 Mar; 16(3):738-45. PubMed ID: 16308692
[TBL] [Abstract][Full Text] [Related]
18. Preoperative esophageal cancer staging: magnetic resonance imaging of lymph node with ferumoxtran-10, an ultrasmall superparamagnetic iron oxide.
Nishimura H; Tanigawa N; Hiramatsu M; Tatsumi Y; Matsuki M; Narabayashi I
J Am Coll Surg; 2006 Apr; 202(4):604-11. PubMed ID: 16571430
[TBL] [Abstract][Full Text] [Related]
19. Interstitial MR lymphography with iron oxide particles: results in tumor-free and VX2 tumor-bearing rabbits.
Taupitz M; Wagner S; Hamm B; Binder A; Pfefferer D
AJR Am J Roentgenol; 1993 Jul; 161(1):193-200. PubMed ID: 8517301
[TBL] [Abstract][Full Text] [Related]
20. Rapid-clearance iron nanoparticles for inflammation imaging of atherosclerotic plaque: initial experience in animal model.
Sigovan M; Boussel L; Sulaiman A; Sappey-Marinier D; Alsaid H; Desbleds-Mansard C; Ibarrola D; Gamondès D; Corot C; Lancelot E; Raynaud JS; Vives V; Laclédère C; Violas X; Douek PC; Canet-Soulas E
Radiology; 2009 Aug; 252(2):401-9. PubMed ID: 19703881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
